
Kuwait's Dasman Diabetes Institute adopts special strategy for treating diabetes
Dr. Faisal Al-Rifai, the center's Director General, explained the strategy in a press statement, noting that excerpts were published by the renowned journal, Genetics Review Nature.
Dasman Institute's vision is distinguished with a method, different from the conventional genome projects, integrating the genetic information with living and ecological factors with such approach deepening understanding of complex diseases namely the second type of diabetes, Dr. Al-Rifai said.
The institute has drawn up this strategy after a series of workshops, conferences, specialized initiatives namely the precision medicine workshop that had been held in coordination with American academies.
Dr. Al-Rifai underscored the high significance of the institute effort at this level amid hike of diabetic and obese cases in Kuwait, mentioning aggravating non-genetic factors such as the hard climatic conditions and pollution.
The institute conducts scientific researches, works out innovative programs, provides comprehensive education for improving life of the patients and stem spread of the disease in the country.
All KUNA right are reserved © 2025. Provided by SyndiGate Media Inc. (Syndigate.info).
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

The National
6 hours ago
- The National
Sir Richard Branson joins jury for Zayed Sustainability Prize
is among the high-profile names confirmed as members of the jury for the Zayed Sustainability Prize on Tuesday. Other names include Dr Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade, Shamma bint Suhail Faris Al Mazrui, Minister of Community Development, Mariam Al Mehairi, Head of the Office of International Affairs, Ahmed Ali Al Sayegh, Minister of State, Dr Nawal Al Hosany, UAE's Permanent Representative to the International Renewable Energy Agency, Olafur Ragnar Grimsson, former President of Iceland, Dr Andreas Jacobs, Chairman of INSEAD, Wang Chuan-fu, chairman and CEO of BYD, Hindou Oumarou Ibrahim, President, Indigenous Women & Peoples Association of Chad Cochair, and Dr Ing Christian Bruch, President and CEO of Siemens Energy. The Zayed Sustainability Prize, now in its 17th year, received 7,761 entries from 173 countries for its 2026 awards event, vying for recognition in its six categories of Health, Food, Energy, Water, Climate Action and Global High Schools. Delivering sustainable solutions The surge in applications marked a 30 per cent increase on the previous awards cycle, with a notable increase in technology-focused projects such as AI and FinTech tools. 'The record number of submissions to this year's prize cycle reflects a growing global commitment to practical, scalable solutions that deliver long-term impact," said Dr Sultan Al Jaber, Minister of Industry and Advanced Technology, and director general of the Zayed Sustainability Prize. "Across all categories, the increased use of AI and other advanced technologies highlights how innovation is being harnessed to drive inclusive, community-led progress." The prize, which honours the legacy of UAE Founding Father, the late Sheikh Zayed bin Sultan Al Nahyan, empowers small to medium-sized enterprises, non-profit organisations and high schools to deliver high-impact, sustainable solutions. Analysis of the 2026 cycle has shown 85 per cent of submissions came from developing or emerging economies, with India, Ethiopia, Uzbekistan, Brazil and Indonesia among the top contributing nations. Winners will be announced at the Zayed Sustainability Prize Awards Ceremony on January 13, 2026, during Abu Dhabi Sustainability Week. Each of the five category winners will receive $1 million, while high schools – representing the world's regions – will be awarded $150,000 each to implement or expand their sustainability projects.


The National
11 hours ago
- The National
Smaller portions and high-protein, the 'Ozempic menu' has arrived in Dubai
A Dubai restaurant has introduced a high-protein, smaller-portion menu designed specifically for people using weight-loss injections. Mediterranean restaurant The Banc Dubai says its Mini Bancer menu comprises of their most popular dishes and drinks, but reimagined as lighter and "more intentional" portions. Highlights include a half-sized grilled sea bream and barbecue melt chicken, alongside scaled-down starters, which include lamb kebab, tiger prawns and wagyu beef tartare. Dessert classics also come in petite portions, from baklava bites to half-sized apple pie. GLP-1 drugs, marketed under brand names such as Ozempic, Mounjaro and Wegovy, work by slowing digestion and signalling the brain to promote a feeling of fullness, which can lead to reduced appetite and weight loss. The Banc Dubai says their new menu was first trialed at their London location before being introduced in the UAE. "People are still dining out – they're just arriving less hungry," says Mazlum Topcu, co-founder of The Banc. "What this new guest really wants is the chance to eat less without drawing attention to it in front of the whole restaurant. 'Some diners don't want to admit they're on the jab. They'll order a big spread, push food around their plate and hope someone else does the heavy lifting. The funny thing is that half the table is probably doing the same thing – so you end up with too much food and unnecessary waste. Our approach makes it easier for everyone to eat the way they want, without the fuss." While it might be new to the UAE, The Banc Dubai is not the first to introduce a so-called "Ozempic menu" as an increasing number of GLP-1 users say they are dining out less. Earlier this year, a survey of 1,000 GLP-1 users in the US by Bloomberg Intelligence found 54 per cent of respondents said they dined out significantly less or less frequently since starting the medication. About the same percentage reported ordering less takeout. In a Morgan Stanley survey in April last year, about two-thirds of GLP-1 users said they spent less money at restaurants, while 31 per cent said they cut back on groceries. Clinton Hall, a group of burger and beer restaurants in New York City known for large portions, recently introduced a Teeny Weeny Mini Meal that includes a petite hamburger, a few fries and a small beer. 'It 100 per cent is targeting the growing number of GLP-1 users,' Greg Mecane, the group's marketing director told While not specifically targeted at GLP-1 users, international chain The Cheesecake Factory also has a "SkinnyLicious" menu, including at its UAE branches, which features smaller sizes and lower calorie dishes. At Town restaurant in London, which opened in May, diners can order half-portions of selected main menu items, as well as desserts. 'We absolutely design dishes specifically for the Mounjaro generation,' owner Jonathan Downey told The Times. "We thought we were just giving people more options, but it turns out to be part of the zeitgeist." And the popularity of these drugs is only set to grow, with Morgan Stanley analysts estimating the market for GLP-1s to be worth $105 billion by 2030. They also estimate that 31.5 million people will take GLP-1s by 2035.


Zawya
12 hours ago
- Zawya
A Global Milestone: Dr. Soliman Fakeeh Hospital in Jeddah receives accreditation for 14 centers of excellence from SRC
In a remarkable and unprecedented global achievement that adds to its legacy of excellence, Dr. Soliman Fakeeh Hospital in Jeddah has been awarded accreditation for 14 Centers of Excellence by the Surgical Review Corporation (SRC) across various medical and surgical specialties—setting a world record for the highest number of Centers of Excellence accredited by SRC within a single hospital. This prestigious international recognition reflects the hospital's deep commitment to implementing 10 rigorous global standards, ensuring the delivery of safe, comprehensive, and high-quality patient care. The accredited specialties include: 1. Robotic Surgery 2. Urology 3. Orthopedic Surgery 4. Spine Surgery 5. Surgery of the Hand 6. Colorectal Surgery 7. Hernia Surgery 8. Plastic Surgery 9. Endoscopy 10. Ear, Nose & Throat (ENT) 11. Ophthalmology 12. Minimally Invasive Gynecology 13. Specialized Anesthesia in Obesity Surgery 14. Specialized Anesthesia in Orthopedic Surgery These accreditations are based on the hospital's adherence to ten rigorous global standards developed by SRC for Centers of Excellence. These include institutional commitment with a clear vision and a quality-first culture, certified medical expertise from highly qualified physicians with outstanding surgical records, trusted medical leadership to oversee program efficiency, and comprehensive consultative services with ongoing medical support for all medical and surgical cases. Additional standards include the use of state-of-the-art equipment and advanced technology with fully trained staff, the availability of a qualified and dedicated medical and surgical teams with consistent on-call coverage, the application of standardized clinical pathways with precise protocols to ensure optimal care, and well-trained support teams including program coordinators, nurses, assistants, and specialized surgical staff. Patient education is also prioritized through the provision of clear information and the obtaining of informed consent for all procedures with a shared decision-making approach. There is also a firm commitment to ongoing quality evaluation, outcome monitoring, and full compliance with data protection regulations. Dr. Mazen Fakeeh, President of Fakeeh Care Group, expressed his pride in this exceptional global achievement, reaffirming the hospital's commitment to delivering specialized, world-class healthcare that meets patients' expectations and supports the vision of Fakeeh Care Group for excellence, leadership, and innovation in healthcare. It's worth noting that the Surgical Review Corporation (SRC) is an independent, global, non-profit organization dedicated to accrediting hospitals, surgeons, and surgical centers according to the highest standards of quality and patient safety. The Center of Excellence designation is awarded only after a comprehensive and rigorous evaluation process that ensures healthcare services are advanced, safe, and aligned with the best global medical practices.